-
1
-
-
0027378724
-
Effect of alpha-interferon treatment in patients with hepatitis Be antigen-positive chronic hepatitis B
-
Wong DKH, Cheung AM, O'Rourke K et al. Effect of alpha-interferon treatment in patients with hepatitis Be antigen-positive chronic hepatitis B. Ann Intern Med 1993; 119: 312-323.
-
(1993)
Ann Intern Med
, vol.119
, pp. 312-323
-
-
Wong, D.K.H.1
Cheung, A.M.2
O'Rourke, K.3
-
2
-
-
0028679078
-
Comparative study of three doses of interferon-α2a in chronic active hepatitis B
-
Thomas HC, Lok ASF, Carreno V et al. Comparative study of three doses of interferon-α2a in chronic active hepatitis B. J Vir Hep 1994; 1: 139-148.
-
(1994)
J Vir Hep
, vol.1
, pp. 139-148
-
-
Thomas, H.C.1
Lok, A.S.F.2
Carreno, V.3
-
3
-
-
0026525117
-
Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon
-
Pastore G, Santantonio T, Milella M et al. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon. J Hepatol 1992; 14: 221-225.
-
(1992)
J Hepatol
, vol.14
, pp. 221-225
-
-
Pastore, G.1
Santantonio, T.2
Milella, M.3
-
4
-
-
0026514922
-
A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg
-
Fattovich G, Farci P, Rugge M et al. A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992; 15: 584-589.
-
(1992)
Hepatology
, vol.15
, pp. 584-589
-
-
Fattovich, G.1
Farci, P.2
Rugge, M.3
-
5
-
-
0028679793
-
Treatment of chronic hepatitis B
-
Lok ASF. Treatment of chronic hepatitis B. J Virol Hep 1994; 1: 105-124.
-
(1994)
J Virol Hep
, vol.1
, pp. 105-124
-
-
Lok, A.S.F.1
-
7
-
-
0028305082
-
Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents
-
Mutchnick MG, Ehrinpreis MN, Kinzie JL et al. Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents. Antivir Res 1994; 24: 245-257.
-
(1994)
Antivir Res
, vol.24
, pp. 245-257
-
-
Mutchnick, M.G.1
Ehrinpreis, M.N.2
Kinzie, J.L.3
-
8
-
-
0026042722
-
Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial
-
Mutchnick MG, Appelman HD, Chung HT et al. Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial. Hepatology 1991; 14: 409-415.
-
(1991)
Hepatology
, vol.14
, pp. 409-415
-
-
Mutchnick, M.G.1
Appelman, H.D.2
Chung, H.T.3
-
9
-
-
0002718823
-
2 interferon treatment of HBsAg, HBeAb, HBV-DNA positive chronic active hepatitis
-
2 interferon treatment of HBsAg, HBeAb, HBV-DNA positive chronic active hepatitis (abstract). Hepatology 1992; 16: 67A.
-
(1992)
Hepatology
, vol.16
-
-
Rezakovic, I.1
Mondazzi, L.2
Asti, L.3
-
10
-
-
0026598436
-
Genetic variation in hepatitis B virus
-
Carman WF, Thomas HC. Genetic variation in hepatitis B virus. Gastroenterology 1992; 102: 711-719.
-
(1992)
Gastroenterology
, vol.102
, pp. 711-719
-
-
Carman, W.F.1
Thomas, H.C.2
-
11
-
-
0025362461
-
Relationship between histology, aminotransferase levels, and viral replication in chronic hepatitis B
-
Mills CT, Lee E, Perrillo R. Relationship between histology, aminotransferase levels, and viral replication in chronic hepatitis B. Gastroenterology 1990; 99: 519-524.
-
(1990)
Gastroenterology
, vol.99
, pp. 519-524
-
-
Mills, C.T.1
Lee, E.2
Perrillo, R.3
-
13
-
-
0025759062
-
Neutralizing antibodies to IFNα: Relative frequency in patients treated with different interferon preparations
-
Antonelli G, Currenti M, Turriziani U et al. Neutralizing antibodies to IFNα: Relative frequency in patients treated with different interferon preparations. J Infect Dis 1991; 163: 882-885.
-
(1991)
J Infect Dis
, vol.163
, pp. 882-885
-
-
Antonelli, G.1
Currenti, M.2
Turriziani, U.3
-
14
-
-
0019813866
-
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
-
Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
-
(1981)
Hepatology
, vol.1
, pp. 431-435
-
-
Knodell, R.G.1
Ishak, K.G.2
Black, W.C.3
-
16
-
-
0025203837
-
Clinical pharmacokinetics of interferons
-
Wills RJ. Clinical pharmacokinetics of interferons. Clin Pharmacokinet 1990; 19: 390-399.
-
(1990)
Clin Pharmacokinet
, vol.19
, pp. 390-399
-
-
Wills, R.J.1
-
17
-
-
0023821633
-
Human lymphoblastoid interferon for the treatment of chronic hepatitis B
-
Mazzella G, Saracco G, Rizetto M et al. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. Am J Med 1988; 85: 141-142.
-
(1988)
Am J Med
, vol.85
, pp. 141-142
-
-
Mazzella, G.1
Saracco, G.2
Rizetto, M.3
-
18
-
-
0026463550
-
Therapy for chronic hepatitis B with lymphoblastoid interferon-α and levamisole
-
Fattovich G, Giustina G, Brollo L et al. Therapy for chronic hepatitis B with lymphoblastoid interferon-α and levamisole. Hepatology 1992; 16: 1115-1119.
-
(1992)
Hepatology
, vol.16
, pp. 1115-1119
-
-
Fattovich, G.1
Giustina, G.2
Brollo, L.3
-
19
-
-
0025347975
-
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
-
Perrillo RP, Schiff ER, Davis GL et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295-301.
-
(1990)
N Engl J Med
, vol.323
, pp. 295-301
-
-
Perrillo, R.P.1
Schiff, E.R.2
Davis, G.L.3
-
20
-
-
0027476702
-
Repeated courses of α-interferon for treatment of chronic hepatitis type B
-
Janssen HLA, Schalm SW, Berk L et al. Repeated courses of α-interferon for treatment of chronic hepatitis type B. J Hepatol 1993; 17 (3):S47-S51.
-
(1993)
J Hepatol
, vol.17
, Issue.3
-
-
Janssen, H.L.A.1
Schalm, S.W.2
Berk, L.3
|